NCT05489211 2025-07-11Study of Dato-Dxd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)AstraZenecaPhase 2 Recruiting582 enrolled
NCT00751205 2014-10-28Prevention of Sagopilone-induced Neurotoxicity With Acetyl-L-Carnitine (ALC)BayerPhase 2 Completed150 enrolled